2024 Annual Aspen Allergy Conference

Aspen, CO US
July 21, 2024 to July 25, 2024

The Aspen Allergy Conference is an interactive four consecutive half-day and thematic meeting with educational sessions including: Asthma, Allergy, Immunodeficiency and COVID. Each State of the Art speaker is selected by their expertise in the topic they are asked to speak. Each lecture is 45 minutes in length with 15 minutes of questions, answers and scientific discussion. The discussion time is protected as a premium advantage for the attendee to maximize the learning experience. There is also ample time for the speaker and attendees to discuss the basic science, translational and clinical topics at length during the course of the meeting. One oral abstract per day is included in the program with a five-minute question and answer period. In addition, posters are included, typically 15-20, that are submitted by physicians including fellows-in-training on topics pertinent to Allergy, Asthma and Immunology. Formal and informal times are included for the presenters and attendees to discuss the scientific basis of the posters at this meeting. Our conference is unique holding two “Meet the Professor” question and answer sessions along with a Nature Botany Walk.

Registration Fees
Attendee TypeFee
Colorado Allergy & Asthma Society (CAAS) Member$0.00
Speaker/Presenting Faculty/Travel Grants$0.00
Non CAAS Physician/PA/Nurse$500.00
Abstract Presenters$500.00
Pharmaceutical Representatives$1000.00

Online registration will remain open through 8:00 a.m on Monday, July 15.

Credit claiming will be available through June 30, 2025. Credit requests on or after July 1, 2025 will be subject to an administrative fee.


Target Audience

  • Allergist/immunologists
  • Fellows-in-training
  • Nurse Practitioners
  • Nurses

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe cutting-edge approaches to the most pressing issues in allergy/immunology, including climate change and agriculture, asthma, anaphylaxis, communication in allergy.
  • Analyze current medical practice and develop strategies to improve patient care across all relevant allergy/immunology topics.
  • Evaluate therapeutic options related to allergic disease and immune deficiency for effective treatment of patients with these conditions.
Available credit: 
  • 12.50 Attendance
    Attendance credit.
  • 12.50 CME
    CME credit.
Course opens: 
Course expires: 
Event starts: 
07/21/2024 - 5:00pm CDT
Event ends: 
07/25/2024 - 11:00am CDT


Sunday, July 21, 2024

Session: Claman Lecture
Peter J. Hoetz, MD
Dean for the National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas


Monday, July 22, 2024 

Session: Climate Change and Allergy 

Overview of Climate Change in Allergy
David B. Peden, MD
Senior Associate Dean for Translational Research, UNC School of Medicine Medical Director, Center for Environmental Medicine, Asthma and Lung Biology Harry S. Andrews Distinguished Professor of Pediatrics, UNC School of Medicine, Chapel Hill, North Carolina

Climate Change and Agriculture
Jill Poole, MD
Division Chief, Allergy & Immunology, Professor, University of Nebraska Medical Center, Omaha, Nebraska

Climate Change and Air Quality
Wayne E. Cascio, MD
Director, Center for Public Health and Environmental Assessment at US Environmental Protection Agency, Durham, North Carolina


Tuesday, July 23, 2024

Session: Asthma

Imaging and Asthma
David Lynch, MD
Professor, Radiology-Diagnostics, National Jewish Health, Denver, Colorado

Overview of Asthma in Precision Medicine from Biologics in Other Treatments
Reynold A. Panettieri, Jr., MD
Vice Chancellor for Translational Medicine and Science Director, Rutgers Institute for Translational Medicine and Science Professor of Medicine, Robert Wood Johnson Medical School Emeritus Professor of Medicine, University of Pennsylvania, Molecular Nanomechanical Mapping of Histamine-Induced Smooth Muscle Cell Contraction and Shortening, New Brunswick, New Jersey

Pediatric Asthma Starting and Stopping Treatments including Biologics
William Anderson, MD
Associate Program Director, Allergy and Immunology Fellowship, University of Colorado/Children's Hospital Colorado, Co-Director, Multidisciplinary Asthma Clinic, Aurora, Colorado


Wednesday, July 24, 2024

Session: Anaphylaxis

Overview in Anaphylaxis
Marcus Shaker, MD
Professor of Pediatrics and Medicine, Geisel School of Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire

Role of Mass Cells in Anaphylaxis
Jonathan Lyons, MD
Laskar Scholar, Chief, Translational Allergic Immunopathology Unit, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland

Treatment of Anaphylaxis including New Approaches
Melanie Dispenza, MD, PhD
Assistant Professor of Medicine, John Hopkins Medicine, Baltimore, Maryland


Thursday, July 25, 2024

Session: Communication in Allergy 

Guidelines and Practice
Nicholas Rider, DO
Chair, Division of Clinical Informatics; Associate Professor of Pediatrics, Texas Children's Hospital, Houston, Texas

Social Media
Payel Gupta, MD
Pediatrics, Allergy and Immunology, Internal Medicine, Mount Sinai, New York

Telehealth in Allergy
Alison Ramsay, MD
Clinical Assistant Professor, Department of Medicine, Allergy/Immunology and Rheumatology, Rochester Regional Health, Rochester, New York


Hotel Jerome
330 East Main Street
Aspen, CO 81611
United States

The information disclosed by the presenters and planning committee members was reviewed in accordance with the AAAAI Disclosure Policy.
All potential conflicts of interest were mitigated by the planners, faculty, and reviewers prior to their participation in the development of this activity.

Planning Committee

William Anderson, MD FAAAAI
University of Colorado School of Medicine, Aurora, CO
Relevant relationships: None

Karen Andrews, MD
Boulder Medical Center, Boulder, CO
Relevant relationships: None

Dan Atkins, MD FAAAAI
Children's Hospital Colorado, Aurora, CO
Relevant relationships: None

Nicole Barberis, MD
Denver Allergy, Lakewood, CO
Relevant relationships: speaker: Sanofi

Maureen Egan Bauer, MD FAAAAI
University of Colorado Denver, Denver, CO
Relevant relationships: TBD

Donna Bratton, MD
National Jewish Health, Cherry Hills Village, CO
Relevant relationships: TBD

Stephen Dreskin, MD PhD FAAAAI
University of Colorado Denver, Denver, DO
Relevant relationships: consultant: Medical Expert Panel, UKKO, Inc.; research grant: Genentech Inc, NIAID

Cullen Dutmer, MD
Children's Hospital Colorado, Aurora, CO
Relevant relationships: advisory board: Horizon Therapeutics; consultant: Enzyvant Therapeutics

David M. Fleischer, MD FAAAAI
Children's Hospital Colorado, Denver, CO
Relevant relationships: TBD

James Wesley Fulton, MD
Asthma and Allergy Associates, Colorado Springs, CO
Relevant relationships: TBD

Flavia Hoyte, MD
National Jewish Health, Denver, CO
Relevant relationships: advisory board: Astra Zeneca, Genentech, GSK, Sanofi, TEVA; consultant: Sanofi, GSK, Genentech; stocks: Amgen, Johnson & Johnson, Merck

John M. James, MD FAAAAI
Food Allergy Consulting and Education Services, LLC, Fort Collins, CO
Relevant relationships: none

Charles Kirkpatrick, MD FAAAAI
University of Colorado Health Science Center, Denver, CO
Relevant relationships: None

Bruce Lanser, MD MPH FAAAAI
National Jewish Health, Denver, CO
Relevant relationships: none

Harold S. Nelson, MD FAAAAI
National Jewish Health, Denver, CO
Relevant relationships: none

Lanny Rosenwasser, MD FAAAAI
University of Colorado Anschutz School of Medicine, Denver, CO
Relevant relationships: None

Alan Schocket, MD MSHA
University of Colorado, Denver, CO
Relevant relationships: None

Gary Siegel, MD
MD Allergy and Immunology, Denver, CO
Relevant relationships: None

William Silvers, MD
University of Colorado School of Medicine, Denver, CO
Relevant relationships: None

Jenny Stitt, MD FAAAAI
University of Colorado, Aurora, CO
Relevant relationships: Genentech (research grant)



William Anderson, III, MD
University of Colorado School of Medicine, Aurora, CO
Relevant relationships: TBD

Melanie C. Dispenza, MD PhD FAAAAI
Johns Hopkins University School of Medicine, Balitimore, MD
Relevant relationships: TBD

Payel Gupta, MD
ENT and Allergy Associates, Tarrytown, PA
Relevant relationships: TBD

Jonathan Lyons, MD
UCSD Allergy & Immunology, San Diego, CA
Relevant relationships: TBD

Reynold A. Panettieri Jr., MD
Rutgers University, Bensalem, PA
Relevant relationships: TBD

David B. Peden, MD MS FAAAAI
University of North Carolina, Chapel Hill, NC
Relevant relationships: TBD

Jill A. Poole, MD FAAAAI
University of Nebraska Medical Center, Omaha, NE
Relevant relationships: TBD

Allison Ramsey, MD FAAAAI
Rochester Regional Health, Rochester, NY
Relevant relationships: TBD

Nick L. Rider, DO FAAAAI
Virginia Tech Carilion School of Medicine, Forest, VA
Relevant relationships: TBD


Content Reviewers

Robert Corriel, MD FAAAAI
Lake Success Allergy and Clinical Immunology, Lake Success, NY
Relevant relationships: None




AAAAI Disclosure Policy

Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:

  • Employment. Name of employer and job title.
  • Financial interests. All organizations, other than the employer, from which the faculty member receives annual remuneration in any amount (including grants, honoraria and consulting fees).
  • Research interests. All organizations which support research projects for which the faculty member serves as an investigator.
  • Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
  • Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
  • Gifts. All organizations from which the faculty member have received a gift of any amount in the last year.
  • Other interests. All interests of the faculty member that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AAAAI and Aspen Allergy Conference. The AAAAI is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement
The American Academy of Allergy, Asthma & Immunology designates this live activity for a maximum of 12.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit Claiming Period
Credit claiming for this activity will expire at 11:59 pm on June 30, 2025. Requests to claim credit on or after July 1, 2025 will be subject to an administrative fee.

Medium and Method of Physician Participation for a Live Activity
Follow these steps to complete the activity:

  1. Register for the activity.
  2. Review the CME and Disclosure information.
  3. Attend the meeting. Be sure to sign in or collect the attendance code from the event administrator.
  4. Complete the activity evaluation.
  5. Claim your credits. Enter only the number of credits earned based on your participation in the activity.
  6. Print or save your certificate.

Activity-related questions should be directed to Jill Hibbeln, illhibbeln@gmail.com, at Aspen Allergy Conference

Registration and credit claiming questions should be directed to cme@aaaai.org.

Available Credit

  • 12.50 Attendance
    Attendance credit.
  • 12.50 CME
    CME credit.


Please login or register to take this course.
By registering for this educational activity you are confirming that you have read the Privacy and Data Protection Notice and agree to the terms as outlined below:
Privacy and Data Protection Notice

The American Academy of Allergy, Asthma & Immunology (AAAAI) takes your privacy seriously. AAAAI will only use your personal information to administer your registration, attendance, and credit claiming/attendance record for this activity, to provide services that you have requested from AAAAI and otherwise as you may expressly consent. A complete copy of AAAAI’s Legal and Privacy Notices, the terms of which are incorporated herein, can be found here.

By providing consent, you are allowing AAAAI to process your personal data. AAAAI will collect and store information you provide in the Registration/Housing Forms for the purposes of enabling us to register your attendance at the activity; to assist with administrative, planning and marketing purposes; and to allow the compilation and analysis of statistics relevant to AAAAI.

The information you provide in the Registration/Housing Forms, and information provided at any other time during this activity, including without limitation any feedback obtained during the activity, will be used by AAAAI to offer, provide and continue to improve its educational activities and other services. The AAAAI will also use your email address to communicate important information regarding this activity and for marketing purposes for future activities. AAAAI will not otherwise, without your consent, use or disclose your personal information for any purpose unless it would reasonably be expected that such a purpose is related to the offer, provision and improvement of the activity or where such purpose is permitted or required by law.

For courses/events with industry support and/or exhibitors, The AAAAI may disclose some information that is collected in the Registration Form such as your name, credentials, title/position, organization, and mailing address to exhibitors and industry supporters for marketing purposes such as to receive mailed literature. In addition to, but separate from, your consent regarding being contacted by exhibitors and industry supporters with mailed literature, when you visit sponsored areas within the virtual platform for an online event (such as, but not limited to, an exhibitor’s virtual exhibit booth), that organization will receive your personal contact information (name, credentials, title/position, organization, mailing address, phone number, email address and NPI number, if applicable). If you do not want to share your personal contact information with any/all of those organizations, please do not visit those areas within our virtual platform. By accessing any/all of those areas in our virtual platform, you are consenting to share your personal contact information with all organizations whose sponsored areas you visit in our virtual platform. If you attend this activity in person, and provide your contact information to an exhibitor or industry supporter (including allowing them to scan your name badge), you are consenting to share your personal contact information with that organization. You have the right to decline an exhibitor and/or industry supporter’s request for your personal contact information. AAAAI does not control the use or distribution of personal contact information transferred when you visit a sponsored area in the virtual platform or, if in person, when you share your personal contact information, and as such, AAAAI shall not be held responsible for any misuse of your personal data obtained by exhibitors or industry supporters in this manner. You have the right to ask the exhibitor or industry supporter questions about how they will use your personal data, how long it will be retained and if they will share information with third parties.

After you have submitted your personal contact information in the registration form, you may change your preferences for receiving emails by following the instructions below:
·    To change your preferences for receiving emails from AAAAI regarding future annual meetings and/or other in-person and online education programs, please visit http://aaaai.execinc.com/edibo/Profile
·    For events where industry support or exhibitions are involved please email cme@aaaai.org to change your consent to be contacted by the industry supporters and exhibitors of that activity.

NOTE: AAAAI  may be photographing this activity. These photographs, along with your name, may be used in AAAAI publications or on the AAAAI website. If you do not want your photo used, please inform the staff photographer at the time the photograph is taken. AAAAI may also be audio recording education sessions during this activity. If you verbally submit any questions for Question & Answer sessions (Q&A), you are agreeing to be recorded and to have that recording available in enduring materials. If you prefer not to be audio recorded, please submit any questions you have in writing.

I understand that it is my right to withhold consent to the above Privacy and Data Protection Notice, or to withdraw my previous consent at any time. I further understand that without my consent, it is not possible to process my registration/housing request for this activity. Please contact the AAAAI Education Team at (414) 272-6071 if you have any further questions about how this will affect your registration/housing request for this activity.

Required Hardware/software

One of the two latest versions of Google Chrome, Microsoft Edge, Mozilla Firefox, or Safari.

Internet Explorer is no longer supported.